Investor Ideas, Trading Ideas and Stocks to Watch : #AIEye #Podcast 515: GBT (OTCPINK: $GTCH) Engages M2 to Help with qTerm FDA Approval, and C3.ai (NYSE: $AI) Announces General Availability of Ex Machina; #artificialintelligence

Thursday, January 28, 2021

#AIEye #Podcast 515: GBT (OTCPINK: $GTCH) Engages M2 to Help with qTerm FDA Approval, and C3.ai (NYSE: $AI) Announces General Availability of Ex Machina; #artificialintelligence

#AIEye #Podcast 515: GBT (OTCPINK: $GTCH) Engages M2 to Help with qTerm FDA Approval, and C3.ai (NYSE: $AI) Announces General Availability of Ex Machina; #artificialintelligence

#AI in Manufacturing to Reach $4.798 Billion by 2026

Point Roberts WA, Vancouver BC – January 28, 2021 – Investorideas.com (www.investorideas.com), a global investor news source covering Artificial Intelligence (AI) brings you today’s edition of The AI Eye- watching stock news, deal tracker and advancements in artificial intelligence – featuring technology company GBT Technologies Inc. (OTCPINK:GTCH).

Listen to today’s podcast:

https://www.investorideas.com/Audio/Podcasts/2021/012821-AI-Eye.mp3

Read this in full at https://www.investorideas.com/news/2021/artificial-intelligence/01282GTCH-AI.asp

Hear the Ai Eye on Spotify

Today’s Column- The AI Eye- Watching stock news, deal tracker and advancements in artificial intelligence

Stocks discussed: (OTCPINK:GTCH) (NYSE:AI) (NYSE:ED)

GBT Technologies Inc. (OTC PINK:GTCH, has engaged M Squared Associates (M2) to assist with developing the FDA premarket strategy for its qTerm human vital signs device. According to the press release, M2 provides “a full range of regulatory, quality and clinical consulting services to US and international medical technology firms.” GBT’s CTO Danny Rittman said:

"We would like to bring our qTerm device to the highest standards within this domain and FDA clearance will demonstrate that the device is safe and effective for its intended use and confirm compliance with regulations and guidelines. Our objectives are to assure qTerm’s credibility as part of our plans for national commercialization. The technology is intended for personal and clinical use and will also be evaluated for remote telemedicine operation. Therefore, an extra focus will be on its cybersecurity system and protocol. The FDA review process will include evaluation of hardware and software systems, including functional verification and validation testing performance data. A comprehensive assessment of risks, data analysis, and cybersecurity requirements will be conducted. In addition, a thorough review of its development environment, revision history, and unresolved anomalies will be done according to FDA guidelines. qTerm device is a non-invasive device to measure human vitals and includes an intelligent analytics system. The FDA submission process is involved, with complex regulatory challenges that are typically associated with advanced technologies and therefore we decided to hire experts in the field."

For more on qTerm, and in particular on its FDA approval, check out a recent interview with Danny Rittman on the AI Eye:

https://www.investorideas.com/news/2021/artificial-intelligence/01271GTCH-qTerm.asp

C3.ai, Inc. (NYSE:AI) has announced the general availability of C3 AI Ex Machina, described in the press release as “a next-generation predictive analytics application that empowers anyone to develop, scale, and produce AI-based insights without writing code.” Chris Brownlee, Department Manager at Con Edison (NYSE:ED), whose data analysts use Ex Machina, commented:

"C3 AI Ex Machina empowers our analysts to easily harness all our data and assess reliability and safety risks. Our AMI Operations group recently used C3 AI Ex Machina to build predictive models that identified hazardous electric meters at risk of overheating. Using C3 AI Ex Machina, our business analysts are now able to evaluate near-real-time risk scores and immediately schedule prioritized field inspections. C3 AI Ex Machina has dramatically simplified and accelerated our ability to build and deploy machine learning models to address use cases that proactively identify risks and provide safer, more reliable service to our customers."

AI in Manufacturing to Reach $4.798 Billion by 2026

Research published by Valuates Reports finds that the global AI in Manufacturing market will grow from $840 million in 2019 to $4.798 billion by 2026 with a compound annual growth rate (CAGR) of 28.1 percent in the forecast period 2020-2026. An excerpt from the report’s press release outlines trends influencing the market’s growth:

The evolution of industrial IoT and automation is expected to drive the growth of artificial intelligence in the manufacturing market size. In the manufacturing sector, the Industrial Internet of Things (IIoT) plays a key role in implementing AI-based technology. By allowing an architecture that provides real-time information on operational and business systems, industrial IoT makes industrial processes efficient. The AI-based system takes less time and can operate without errors hence. Manufacturing performance is improving, which further contributes to business growth. Furthermore, the growing use of deep learning technology in the manufacturing industry is expected to drive the growth of the AI in manufacturing market size.

Sam Mowers, Investorideas.com

Read and hear other editions of the AI Eye

For a list of artificial intelligence stocks on Investorideas.com visit here

Investors can trade these stocks and other ideas on our site using our list of top stock trading apps including Robinhood , Acorn, Stash and others.

About GBT Technologies Inc.

GBT Technologies Inc. (OTC PINK: GTCH) (“GBT”) (http://gbtti.com) is a development-stage company which considers itself a native IoT creator, developing Internet of Things (IoT) and Artificial Intelligence (AI) enabled mobile technology platforms. GBT has a portfolio of Intellectual Property that, when commercialized, will include smart microchips, mobile and security applications and protocols, and supporting cloud software. GBT’s system envisions the creation of a global mesh network. The core of the system will be its advanced microchip technology that can be installed in any mobile or fixed device worldwide. GBT envisions this system as a low-cost, secure, private mesh network between any enabled devices, providing shared processing, advanced mobile database management/sharing and enhanced mobile features as an alternative to traditional carrier services.

About Investorideas.com - News that Inspires Big Investing Ideas Investorideas.com is a recognized news source publishing third party news, research and original financial content. Learn about investing in stocks and sector trends with our news alerts, articles, podcasts and videos, looking at cannabis, crypto, AI and IoT, mining, sports biotech, water, renewable energy and more. Investor Idea’s original branded content includes the following podcasts and columns : Crypto Corner , Play by Play sports and stock news column, Investor Ideas Potcasts Cannabis News and Stocks on the Move podcast and column, Cleantech and Climate Change , Exploring Mining the AI Eye .

The Investorideas.com podcasts are also available on iTunes, Spotify, Tunein, Stitcher, Spreaker.com, iHeartRadio and Google Play Music.

Visit the Podcast page at Investorideas.com:

https://www.investorideas.com/Audio/

Disclaimer/Disclosure: Investorideas.com is a digital publisher of third party sourced news, articles and equity research as well as creates original content, including video, interviews and articles. Original content created by investorideas is protected by copyright laws other than syndication rights. Our site does not make recommendations for purchases or sale of stocks, services or products. Nothing on our sites should be construed as an offer or solicitation to buy or sell products or securities. All investing involves risk and possible losses. This site is currently compensated for news publication and distribution, social media and marketing, content creation and more. Disclosure is posted for each compensated news release, content published /created if required but otherwise the news was not compensated for and was published for the sole interest of our readers and followers. Contact management and IR of each company directly regarding specific questions. More disclaimer info: https://www.investorideas.com/About/Disclaimer.asp Learn more about publishing your news release and our other news services on the Investorideas.com newswire https://www.investorideas.com/News-Upload/ and tickertagstocknews.com Disclosure: GTCH is a paid monthly featured AI stock on Investorideas.com

Global investors must adhere to regulations of each country. Please read Investorideas.com privacy policy: https://www.investorideas.com/About/Private_Policy.asp

The AI Eye- Watching stock news, deal tracker and advancements in artificial intelligence is an original content brand of Investorideas.com